Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: A randomised controlled trial
Ronald Dahl(Aarhus University Hospital), Ingrid Louise Titlestad(Odense University Hospital), Ari Lindqvist(Helsinki University Hospital), Pascal Wielders(Catharina Ziekenhuis), Heather Wray(Loughborough University), Millie Wang(Loughborough University), Viktoria Samuelsson(AstraZeneca (Sweden)), John Mo(AstraZeneca (Sweden)), Alison Holt(AstraZeneca (United Kingdom))
Cited by 82
Abstract
Related Papers
No related papers found
Powered by citation graph analysis